USPTO Patents Application 09993647

Clcl/ll Ullll# MUftl IU W Icily t;l 1 lt;l 1 1 ricocipi

EFS ID:

1820070

Application Number:

09993647

International Application Number:

Confirmation Number:

1010

Title of Invention:

omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

First Named Inventor/Applicant Name:

Bernd Riedl

Customer Number:

23599

Filer:

John Albert Sopp

Filer Authorized By:

Attorney Docket Number:

BAYER 18A

Receipt Date:

29-MAY-2007

Filing Date:

27-NOV-2001

Time Stamp:

22:21:07

Application Type:

Utility

Payment information:

Submitted with Payment

yes

Payment was successfully received in RAM

$180

RAM confirmation Number

11976

Deposit Account

File Listing:

Document Document Description File Name File Size(Bytes) D M . u ! fl . ,. Page ®
Number K v 7 ' Part /.zip (ifappl.)

1

Information Disclosure Statement

49467

^iuoj riieu

PTO-1449-Filed-5-29-07.pdf

no

3

Warnings:

Information:

This is not an

USPTO supplied IDS tillable form

2

Foreign Reference

1-WO9822103.pdf

1898048

no

38

Warnings:

Information:

Information Disclosure Statement

33153

3

(IDS) Filed

IDS-Filed-5-29-07.pdf

no

4

Warnings:

Information:

This is not an

USPTO supplied IDS tillable form

4

NPL Documents

2-Abou-Alfa.pdf

1050508

no

8

Warnings:

Information:

5

NPL Documents

3-Eisen.pdf

682667

no

6

Warnings:

Information:

6

NPL Documents

4-Jain.pdf

217872

no

3

Warnings:

Information:

7

NPL Documents

5-Ratain.pdf

662615

no

6

Warnings:

Information:

8

NPL Documents

6-Gridelli.pdf

1194288

no

12

Warnings:

Information:

9

NPL Documents

7-Monia.pdf

854977

no

9

Warnings:

Information:

10

NPL Documents

8-Nemunaitis.pdf

1139206

no

11

Warnings:

Information:

11

NPL Documents

9-Holmlund.pdf

157159

no

2

Warnings:

Information:

12

NPL Documents

10-Lorigan.pdf

106895

no

2

Warnings:

Information:

13

NPL Documents

1 1 -Gatzemeier.pdf

94188

no

2

Warnings:

Information:

14

NPL Documents

12-Ciba-Monia.pdf

94188

no

2

Warnings:

Information:

15

NPL Documents

13-PhasellAntisence.pdf

119811

no

1

Warnings:

Information:

16

NPL Documents

14-Rudin.pdf

637106

no

7

Warnings:

Information:

17

NPL Documents

1 5-BreastCancer.pdf

182896

no

3

Warnings:

Information:

NPL Documents

1 6-ColorectalCancer.pdf

1 62846

no

Warnings:

Information:

19

NPL Documents

1 7-ProstateCancer.pdf

167913

no

Warnings:

Information:

20

NPL Documents

1 8-PancreaticCancer.pdf

159203

no

Warnings:

Information:

21

Fee Worksheet (PTO-06)

fee-info. pdf

8180

no

Warnings:

Information:

Total Files Size (in bytes)

9673186

This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt
similar to a Post Card, as described in MPEP 503.

New Applications Under 35 U.S.C. 111

If a new application is being filed and the application includes the necessary components for a filing date (see
37 CFR 1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date
shown on this Acknowledgement Receipt will establish the filing date of the application.

National Stage of an International Application under 35 U.S.C. 371

If a timely submission to enter the national stage of an international application is compliant with the conditions
of 35 U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the
application as a national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt,
in due course.

New International Application Filed with the USPTO as a Receiving Office

If a new international application is being filed and the international application includes the necessary
components for an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the
International Application Number and of the International Filing Date (Form PCT/RO/105) will be issued in due
course, subject to prescriptions concerning national security, and the date shown on this Acknowledgement
Receipt will establish the international filing date of the application.